(Q39656963)

13 September 2017

1 reference

title

Current status and prospects of new radionuclides and radiopharmaceuticals for cardiovascular nuclear medicine (English)

1 reference

13 September 2017

Schelbert HR

1

1 reference

13 September 2017

language of work or name

1 reference

1 April 1987

1 reference

Seminars in Nuclear Medicine

13 September 2017

published in

1 reference

13 September 2017

volume

17

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

145-181

1 reference

Blood flow measurements with radionuclide-labeled particles

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Validation of quantitation of regional myocardial blood flow in vivo with 11C-labeled human albumin microspheres and positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

In vivo quantitation of regional myocardial blood flow by positron-emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Regional myocardial and organ blood flow after myocardial infarction: application of the microsphere principle in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

N-13 ammonia as an indicator of myocardial blood flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

The dependence of accumulation of 13NH3 by myocardium on metabolic factors and its implications for quantitative assessment of perfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Noninvasive assessment of coronary stenoses with myocardial perfusion imaging during pharmacologic coronary vasodilatation. V. Detection of 47 percent diameter coronary stenosis with intravenous nitrogen-13 ammonia and emission-computed tomography i

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Myocardial positron computed tomography with 13N-ammonia at rest and during exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Reversibility of cardiac wall-motion abnormalities predicted by positron tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Measurement of regional myocardial blood flow with N-13 ammonia and positron-emission tomography in intact dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Rubidium-81: A New Myocardial Scanning Agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Myocardial ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Transient ST-segment depression as a marker of myocardial ischemia during daily life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Direct effects of smoking on the heart: silent ischemic disturbances of coronary flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Relation between regional myocardial uptake of rubidium-82 and perfusion: absolute reduction of cation uptake in ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

The character of transient myocardial ischemia: clinical studies and progress using positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Kinetics of rubidium-82 after coronary occlusion and reperfusion. Assessment of patency and viability in open-chested dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Quantification of regional myocardial blood flow in vivo with H215O

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Positron emission tomography of the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Characterization of the functional significance of subcritical coronary stenoses with H(2)15O and positron-emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Heart imaging with cationic complexes of technetium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Evaluation of 99mTc-dichloro bis (1,2-dimethylphosphino) ethane (99mTc-DMPE) for myocardial scintigraphy in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Synthesis and biological evaluation of 17-[131I]iodo-9-telluraheptadecanoic acid, a potential imaging agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Accumulation of radioiodinated 15-(p-iodophenyl)-6-tellurapentadecanoic acid in ischemic myocardium during acute coronary occlusion and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

New myocardial imaging agents: stabilization of radioiodine as a terminal vinyl iodide moiety on tellurium fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Effect of tellurium position on the myocardial uptake of radioiodinated 18-iodotellura-17-octadecenoic acid analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Tellurium-123m-labeled-9-telluraheptadecanoic acid: a possible cardiac imaging agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. IV. In vivo evaluation of acute demand-induced ischemia in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C- 11 palmitic acid in normal myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. II. Kinetics of C- 11 palmitic acid in acutely ischemic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Implications for quantifying myocardial metabolism tomographically

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Localization of viable, ischemic myocardium by positron-emission tomography with 11C-palmitate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Effect of flow-independent reduction of metabolism on regional myocardial clearance of 11C-palmitate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Retention and clearance of C-11 palmitic acid in ischemic and reperfused canine myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

External detection and visualization of myocardial ischemia with 11C-substrates in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Non-invasive analysis of metabolic reactions in body tissues, the case of myocardial fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

USE OF RADIOIODINATED FATTY ACID FOR PHOTOSCANS OF THE HEART

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Myocardial Imaging with123l-Hexadecenoic Acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

The use of 123I-labeled heptadecanoic acid (HDA) as metabolic tracer: Preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Omega-halofatty acids: a probe for mitochondrial membrane integrity. In vitro investigations in normal and ischaemic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Metabolic myocardial imaging with 123I-labeled heptadecanoic acid in patients with angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

External detection of regional myocardial metabolism with radioiodinated hexadecenoic acid in the dog heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

The myocardial elimination rate of radioiodinated heptadecanoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Metabolic fate of radioiodinated heptadecanoic acid in the normal canine heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Dynamic myocardial scintigraphy with 123I-labeled free fatty acids in patients with myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

I-123 labeled hexadecenoic acid in comparison with Thallium-201 for myocardial imaging in coronary heart disease. A preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Biochemical concept and synthesis of a radioiodinated phenylfatty acid for in vivo metabolic studies of the myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Localization of cardiac myosin-specific antibody in myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Experimental myocardial infarct imaging following intravenous administration of iodine-131 labeled antibody (Fab')2 fragments specific for cardiac myosin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Early imaging of experimental myocardial infarction by intracoronary administraion of 131I-labelled anticardiac myosin (Fab')2 fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Histologic, histochemical, autoradiographic and scintigraphic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Monoclonal antibody to cardiac myosin: imaging of experimental myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Subcellular distribution of [3H]amphetamine and [3H]guanethidine and their interaction with adrenergic neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

In vivo characterization of myocardium muscarinic receptors by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Kinetics of in vivo binding of antagonist to muscarinic cholinergic receptor in the human heart studied by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Beta receptor occupancy. Assessment in the intact animal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Relationship between beta-adrenergic receptor numbers and physiological responses during experimental canine myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Use of 11C-triphenylmethylphosphonium for the evaluation of membrane potential in the heart by positron-emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

A comparison between terminally radioiodinated hexadecenoic acid (I-HA) and 201Tl-thallium chloride in the dog heart. Implications for the use of I-HA for myocardial imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2887%2980019-3

10.1016/S0001-2998(87)80019-3

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference